Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
Jaulent, P., Hannoun, S., Kocevar, G., Rollot, F., Durand-Dubief, F., Vukusic, S., Brisset, J.-C., Sappey-Marinier, D., and Cotton, F. (2018). Eur J Radiol (105). p.204–208

Unusual neurologic presentation of aseptic abscesses syndrome
Nicolas, P., Guerrier, O., Benoit, A., Durand-Dubief, F., Raverot, G., Debarbieux, S., Delteil, C., Vasiljevic, A., Jouanneau, E., Cotton, F., et al. (2018). Neurol Neuroimmunol Neuroinflamm (5). p.e469

Efficacy of rituximab in refractory RRMS
Durozard, P., Maarouf, A., Boutiere, C., Ruet, A., Brochet, B., Vukusic, S., Carra-Dalliere, C., Labauge, P., Mathey, G., Debouverie, M., et al. (2018). Mult. Scler.

Diagnostic value of 3DFLAIR in clinical practice for the detection of infratentorial lesions in multiple sclerosis in regard to dual echo T2 sequences
Hannoun, S., Heidelberg, D., Hourani, R., Nguyen, T.T.T., Brisset, J.-C., Grand, S., Kremer, S., Bonneville, F., Guttmann, C.R.G., Dousset, V., et al. (2018). European Journal of Radiology (102). p.146–151

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study
Cobo-Calvo, A., Ruiz, A., Maillart, E., Audoin, B., Zephir, H., Bourre, B., Ciron, J., Collongues, N., Brassat, D., Cotton, F., et al. (2018). Neurology

Oligoclonal Bands in Spinal Fluid Improve the Specificity of Different MRI Criteria for Dissemination in Space to Predict a First Clinical Event in Children with the Radiologically Isolated Syndrome (S51.002)
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brenton, J.N., Brassat, D., Carra-Dalliere, C., Seze, J.D., Dubief, F.D., et al. (2018). Neurology (90). p.S51.002

Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Hacohen, Y., Wong, Y.Y., Lechner, C., Jurynczyk, M., Wright, S., Konuskan, B., Kalser, J., Poulat, A.L., Maurey, H., Ganelin-Cohen, E., et al. (2018). JAMA Neurol (75). p.478–487

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study
Cabre, P., Mejdoubi, M., Jeannin, S., Merle, H., Plumelle, Y., Cavillon, G., Smadja, D., Marignier, R., and Francophone Society of Multiple Sclerosis and OFSEP investigators (2018). J. Neurol. (265). p.917–925

Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
Ciron, J., Audoin, B., Bourre, B., Brassat, D., Durand-Dubief, F., Laplaud, D., Maillart, E., Papeix, C., Vukusic, S., Zephir, H., et al. (2018). Revue Neurologique (174). p.255—264

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS
Lavie, C., Rollot, F., Durand-Dubief, F., Marignier, R., Ionescu, I., Casey, R., Moreau, T., Tourniaire, P., Hutchinson, M., D’Hooghe, M.B., et al. (2018). Multiple Sclerosis Journal (0).

Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients
Calocer, F., Dejardin, O., Droulon, K., Launoy, G., and Defer, G. (2018). PLoS ONE (13). p.e0191646

Caractéristique de la cohorte française des syndromes radiologiques isolés (RIS)
Christine Lebrun-Frénay, R., Céline Callier, Patrick Vermersch, Caroline Papeix, Emmanuelle Le Page, Françoise Durand-Dubief, Pierre Labauge, OFSEP, SFSEP (2018). Revue Neurologique (5961). p.S2–S200

Quelle utilisation des traitements de fond chez des patients ayant une SEP rémittente en France sur la période 1990–2017 ? Éléments de réponse à partir des données de l’Ofsep
Leray, E., Rollot, F., Casey, R., Roux, J., De Seze, J., Laplaud, D., and Vukusic, S. (2018). Revue Neurologique (5961). p.S2–S200

Radiologically isolated syndrome in children: Clinical and radiologic outcomes
Makhani, N., Lebrun, C., Siva, A., Brassat, D., Carra Dallière, C., de Seze, J., Du, W., Durand Dubief, F., Kantarci, O., Langille, M., et al. (2017a). Neurol Neuroimmunol Neuroinflamm (4). p.e395

MOG antibody-related disorders: common features and uncommon presentations
Cobo-Calvo, Á., Ruiz, A., D’Indy, H., Poulat, A.-L., Carneiro, M., Philippe, N., Durand-Dubief, F., Deiva, K., Vukusic, S., Desportes, V., et al. (2017). J. Neurol. (264). p.1945–1955

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
Montcuquet, A., Collongues, N., Papeix, C., Zephir, H., Audoin, B., Laplaud, D., Bourre, B., Brochet, B., Camdessanche, J.-P., Labauge, P., et al. (2017). Mult. Scler. (23). p.1377–1384

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder
Asgari, N., Flanagan, E.P., Fujihara, K., Kim, H.J., Skejoe, H.P., Wuerfel, J., Kuroda, H., Kim, S.H., Maillart, E., Marignier, R., et al. (2017). Neurol Neuroimmunol Neuroinflamm (4). p.e343

Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients
Barros, P.O., Dias, A.S.O., Kasahara, T.M., Ornelas, A.M.M., Aguiar, R.S., Leon, S.A., Ruiz, A., Marignier, R., Araújo, A.C.R.A., Alvarenga, R., et al. (2017). J. Neuroimmunol. (307). p.82–90

An excessive risk of suicide may no longer be a reality for multiple sclerosis patients
Kalson-Ray, S., Edan, G., and Leray, E. (2017). Mult Scler (23). p.864–871

Multiple sclerosis broke my heart
Androdias, G., Bernard, E., Biotti, D., Collongues, N., Durand-Dubief, F., Pique, J., Sanchez, I., Delmas, C., Ninet, J., Marignier, R., et al. (2017). Ann. Neurol. (81). p.754–758

Comparison of MRI Dissemination in Space Criteria for Predicting a First Clinical Event in Children with the Radiologically Isolated Syndrome (S2.001)
Makhani, N., Lebrun, C., Siva, A., Narula, S., Wassmer, E., Brenton, J.N., Dalliere, C.C., Seze, J.D., Dubief, F.D., Langille, M., et al. (2017b). Neurology (88). p.S2.001

L’OFSEP : du soin à la recherche, améliorer nos connaissances sur la sclérose en plaques
Debard, N., Casey, R., Vukusic, S., and investigateurs de l’OFSEP (2017). La Lettre Du Neurologue

Neuromyelitis optica and neuromyelitis optica spectrum disorders
Marignier, R., Cobo Calvo, A., and Vukusic, S. (2017). Curr. Opin. Neurol. (30). p.208–215

Risk of relapse after natalizumab withdrawal: Results from the French TYSEDMUS cohort
Papeix, C., Vukusic, S., Casey, R., Debard, N., Stankoff, B., Mrejen, S., Uhry, Z., Van Ganse, E., Castot, A., Clanet, M., et al. (2016). Neurology - Neuroimmunology & Neuroinflammation (3). p.e297

History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort
Benoit, A., Durand-Dubief, F., Amato, M.-P., Portaccio, E., Casey, R., Roggerone, S., Androdias, G., Gignoux, L., Ionescu, I., Marrosu, M.-G., et al. (2016). Neurology (87). p.1360–1367

Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
Barbin, L., Rousseau, C., Jousset, N., Casey, R., Debouverie, M., Vukusic, S., De Sèze, J., Brassat, D., Wiertlewski, S., Brochet, B., et al. (2016). Neurology (86). p.771–778

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
Kantarci, O.H., Lebrun, C., Siva, A., Keegan, M.B., Azevedo, C.J., Inglese, M., Tintoré, M., Newton, B.D., Durand-Dubief, F., Amato, M.P., et al. (2016). Ann. Neurol. (79). p.288–294

Efficacy of rituximab in refractory neuromyelitis optica
Collongues, N., Brassat, D., Maillart, E., Labauge, P., Ouallet, J.C., Carra-Dalliere, C., Moreau, T., Bourre, B., Papeix, C., Brochet, B., et al. (2016). Mult. Scler. (22). p.955–959

Suivi en imagerie par résonance magnétique des patients avec une sclérose en plaques : comment ?
Cotton, F. (2016). Pratique Neurologique - FMC (7). p.153–158

Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study
Guttmann, C.R., Rousset, M., Roch, J.A., Hannoun, S., Durand-Dubief, F., Belaroussi, B., Cavallari, M., Rabilloud, M., Sappey-Marinier, D., Vukusic, S., et al. (2016). Mult. Scler. (22). p.761–769

Graph Theory-Based Brain Connectivity for Automatic Classification of Multiple Sclerosis Clinical Courses
Kocevar, G., Stamile, C., Hannoun, S., Cotton, F., Vukusic, S., Durand-Dubief, F., and Sappey-Marinier, D. (2016). Front Neurosci (10). p.478

Analgésie locorégionale et risque de poussée du post-partum chez les femmes ayant une sclérose en plaques active au cours de la grossesse
Lavie, C., Rollot, F., Durand-Dubief, F., Marignier, R., Ionescu, I., Frangoulis, B., and Vukusic, S. (2016). Revue Neurologique (172). p.A96–A97

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid
Marignier, R., Ruiz, A., Cavagna, S., Nicole, A., Watrin, C., Touret, M., Parrot, S., Malleret, G., Peyron, C., Benetollo, C., et al. (2016). J Neuroinflammation (13). p.111

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
Pivot, D., Debouverie, M., Grzebyk, M., Brassat, D., Clanet, M., Clavelou, P., Confavreux, C., Edan, G., Leray, E., Moreau, T., et al. (2016). PLoS ONE (11). p.e0167556

A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis
Stamile, C., Kocevar, G., Cotton, F., Durand-Dubief, F., Hannoun, S., Frindel, C., Guttmann, C.R.G., Rousseau, D., and Sappey-Marinier, D. (2016). PLoS ONE (11). p.e0156405

Neuromyelitis optica: a positive appraisal of seronegative cases
Bernard-Valnet, R., Liblau, R.S., Vukusic, S., and Marignier, R. (2015). Eur. J. Neurol. (22). p.1511–1518, e82-83

A longitudinal model for variations detection in white matter fiber-bundles
Stamile, C., Kocevar, G., Cotton, F., Hannoun, S., Durand-Dubief, F., Frindel, C., Rousseau, D., and Sappey-Marinier, D. (2015). A longitudinal model for variations detection in white matter fiber-bundles. In 2015 International Conference on Systems, Signals and Image Processing (IWSSIP), pp. 57–60

Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?
Moroso, A., Deloire, M.S.A., Ruet, A., Ouallet, J.-C., Casey, R., and Brochet, B. (2015). Journal of the Neurological Sciences (354). p.51–55

OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol
Cotton, F., Kremer, S., Hannoun, S., Vukusic, S., Dousset, V., and Imaging Working Group of the Observatoire Français de la Sclérose en Plaques (2015a). J Neuroradiol (42). p.133–140

Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis
Vukusic, S., Durand-Dubief, F., Benoit, A., Marignier, R., Frangoulis, B., and Confavreux, C. (2015). Mult. Scler. (21). p.953–955

[Evolution of Devic’s neuromyelitis optica spectrum disorders]
Bernard-Valnet, R., and Marignier, R. (2015). Presse Med (44). p.401–410

Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC
Hannoun, S., Roch, J.-A., Durand-Dubief, F., Vukusic, S., Sappey-Marinier, D., Guttmann, C.R.G., and Cotton, F. (2015). Brain Behav (5). p.e00307

L’Observatoire français de la sclérose en plaques (OFSEP): établissement d’un protocole commun minimum dans la sclérose en plaques
Cotton, F., Hannoun, S., Kremer, S., Guillaumont, J., and Dousset, V. (2015b). Revue Neurologique (171). p.A65–A66

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study
Leray, E., Vukusic, S., Debouverie, M., Clanet, M., Brochet, B., de Sèze, J., Zéphir, H., Defer, G., Lebrun-Frenay, C., Moreau, T., et al. (2015). PLoS ONE (10). p.e0132033

Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis
Cavallari, M., Ceccarelli, A., Wang, G.-Y., Moscufo, N., Hannoun, S., Matulis, C.R., Jackson, J.S., Glanz, B.I., Bakshi, R., Neema, M., et al. (2014). PLoS ONE (9). p.e101199

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset
Collongues, N., Marignier, R., Jacob, A., Leite, M.I., Siva, A., Paul, F., Zephir, H., Akman-Demir, G., Elsone, L., Jarius, S., et al. (2014). Mult. Scler. (20). p.1086–1094

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity
Marignier, R., Bernard-Valnet, R., Giraudon, P., Collongues, N., Papeix, C., Zéphir, H., Cavillon, G., Rogemond, V., Casey, R., Frangoulis, B., et al. (2013). Neurology (80). p.2194–2200

Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study
Cabre, P., Olindo, S., Marignier, R., Jeannin, S., Merle, H., Smadja, D., and Aegis of French National Observatory of Multiple Sclerosis (2013). J. Neurol. Neurosurg. Psychiatry (84). p.511–516

P296 Double seronegative longitudinally extensive transverse myelitis: preliminary study on 17 patients. E. Maillart, Paris, FR

P301 Myelin oligodendrocyte glycoprotein antibodies predict a favourable outcome in neuromyelitis optica related disorders. A. Cobo-Calvo, Lyon, FR

P302 Myelin oligodendrocyte glycoprotein antibodies spectrum disorder: clinical features and prognostic factors in a cohort of 150 adult patients. A. Cobo-Calvo, Lyon, FR

P303 Prognostic factor for therapeutic response of attacks in anti-AQP4, anti-MOG seropositive and NMO seronegative patients. N. Collongues, Strasbourg, FR

P323 Characteristics of radiologically isolated syndrome (RIS) national French cohort. C. Lebrun-Frenay, Nice, FR

P335 Observatoire Français de la Sclérose en Plaques (OFSEP): a powerful epidemiological tool. R. Casey, Lyon, FR

P738 Big Multiple Sclerosis Data network: data sharing among five large MS registries. P. Iaffaldano, Bari, IT

P1149 Efficacy and safety of alemtuzumab in 150 patients with active relapsing-remitting MS: two-year follow-up in France. X. Ayrignac, Montpellier, FR

P1154 Efficacy of rituximab as a rescue therapy after the failure of second line treatment in relapsing remitting multiple sclerosis: a retrospective observational monocenter study. P. Durozard, Marseille, FR

P1237 Disease-modifying therapies use in primary progressive multiple sclerosis patients in France: data from the OFSEP cohort over the 1996 - 2017 period. E. Leray, Rennes, FR

P1854 Big Multiple Sclerosis Data Network: impact of early treatment on long term disability accumulation in relapsing remitting multiple sclerosis patients. P. Iaffaldano, Bari, IT